Delong Liu

Author PubWeight™ 77.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 2010 5.95
2 Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. N Engl J Med 2015 3.42
3 Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol 2010 2.94
4 Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006 2.75
5 Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function. Immunity 2012 2.16
6 Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res 2012 1.95
7 Ibrutinib and novel BTK inhibitors in clinical development. J Hematol Oncol 2013 1.92
8 MEK and the inhibitors: from bench to bedside. J Hematol Oncol 2013 1.90
9 Fetal mouse phthalate exposure shows that Gonocyte multinucleation is not associated with decreased testicular testosterone. Toxicol Sci 2007 1.75
10 Current management and novel agents for malignant melanoma. J Hematol Oncol 2012 1.53
11 Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application. Biomark Res 2013 1.43
12 First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib. J Hematol Oncol 2010 1.40
13 Novel CD20 monoclonal antibodies for lymphoma therapy. J Hematol Oncol 2012 1.30
14 Reversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cells. Int J Nanomedicine 2008 1.29
15 New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer. J Hematol Oncol 2009 1.24
16 Current management and prognostic features for gastrointestinal stromal tumor (GIST). Exp Hematol Oncol 2012 1.23
17 p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis. J Biol Chem 2006 1.23
18 Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights. J Hematol Oncol 2010 1.18
19 STAT inhibitors for cancer therapy. J Hematol Oncol 2013 1.16
20 Recent advances and novel agents for gastrointestinal stromal tumor (GIST). J Hematol Oncol 2012 1.16
21 Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma. Clin Cancer Res 2011 1.14
22 Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J Clin Invest 2010 1.14
23 B-Raf and the inhibitors: from bench to bedside. J Hematol Oncol 2013 1.14
24 Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest. Carcinogenesis 2004 1.13
25 Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int J Oncol 2004 1.12
26 Dietary nitrate and nitrite modulate blood and organ nitrite and the cellular ischemic stress response. Free Radic Biol Med 2009 1.12
27 Phenylhexyl isothiocyanate inhibits histone deacetylases and remodels chromatins to induce growth arrest in human leukemia cells. Int J Oncol 2006 1.11
28 A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome. J Hematol Oncol 2011 0.99
29 Microarray-based characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans. Arterioscler Thromb Vasc Biol 2009 0.99
30 Testicular gene expression profiling following prepubertal rat mono-(2-ethylhexyl) phthalate exposure suggests a common initial genetic response at fetal and prepubertal ages. Toxicol Sci 2006 0.99
31 P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia. J Hematol Oncol 2008 0.95
32 Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis. Exp Hematol Oncol 2012 0.94
33 Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia. Blood 2011 0.92
34 Side effects related to cancer treatment: CASE 2. Splenic rupture following pegfilgrastim. J Clin Oncol 2005 0.92
35 Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors. Drug Des Devel Ther 2009 0.91
36 A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide. J Hematol Oncol 2012 0.91
37 CD146+ T lymphocytes are increased in both the peripheral circulation and in the synovial effusions of patients with various musculoskeletal diseases and display pro-inflammatory gene profiles. Cytometry B Clin Cytom 2010 0.89
38 Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways. J Hematol Oncol 2008 0.89
39 Phase I study of temozolomide in relapsed/refractory acute leukemia. J Clin Oncol 2002 0.86
40 The phenylhexyl isothiocyanate induces apoptosis and inhibits leukemia cell growth in vivo. Oncol Rep 2006 0.84
41 Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome. Leuk Lymphoma 2005 0.84
42 miR-222 contributes to sex-dimorphic cardiac eNOS expression via ets-1. Physiol Genomics 2013 0.84
43 Palladium-catalyzed allylic alkylation of simple ketones with allylic alcohols and its mechanistic study. Angew Chem Int Ed Engl 2014 0.84
44 High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate. Prostate 2011 0.82
45 Efficient palladium-catalyzed asymmetric allylic alkylation of ketones and aldehydes. Org Biomol Chem 2011 0.80
46 PET scan-positive cat scratch disease in a patient with T cell lymphoblastic lymphoma. Leuk Res 2005 0.80
47 Acute promyelocytic leukemia with tetraploid karyotype: first report in the Western hemisphere and update of previous reports. Leuk Res 2011 0.79
48 T-cryptantigen (TCA) activation in sever pneumonia complicated with multiple organ failure. Transfus Apher Sci 2010 0.79
49 Deficient histone acetylation in acute leukemia and the correction by an isothiocyanate. Acta Haematol 2009 0.79
50 C-N bond cleavage of allylic amines via hydrogen bond activation with alcohol solvents in Pd-catalyzed allylic alkylation of carbonyl compounds. J Am Chem Soc 2011 0.79
51 [Coblation-assisting uvulopalatopharyngoplasty combining coblation-channeling of the tongue for patients with severe OSAHS]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2012 0.78
52 Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials. Biomark Res 2013 0.78
53 Coexistence of inversion 16 and the Philadelphia chromosome in patients with acute myelogenous leukemia. Leuk Lymphoma 2002 0.77
54 Novel influenza A (H1N1) in patients with hematologic malignancies. J Clin Oncol 2009 0.77
55 [Modulation of histone acetylation and induction of apoptosis in SMMC-7721 cells by phenylhexyl isothiocyanate]. Zhonghua Zhong Liu Za Zhi 2010 0.76
56 Hydrogen-bond-activated palladium-catalyzed allylic alkylation via allylic alkyl ethers: challenging leaving groups. Org Lett 2014 0.76
57 Prospective evaluation of 2009 H1N1 influenza A in patients admitted with fever to an oncology unit. Infect Control Hosp Epidemiol 2011 0.76
58 t(3;9;22) 3-way chromosome translocation in chronic myeloid leukemia is associated with poor prognosis. Cancer Invest 2009 0.76
59 Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation. Leuk Res 2009 0.76
60 Journal of hematology & oncology: a journal open to all. J Hematol Oncol 2008 0.75
61 Phenotypic and functional characterization of a mouse model of targeted Pig-a deletion in hematopoietic cells. Haematologica 2009 0.75
62 Sweet fruit from a poisonous kiss. J Hematol Oncol 2010 0.75
63 Long-term follow-up of high-dose mitoxantrone-based induction therapy for patients with newly-diagnosed acute myelogenous leukemia. Twelve year results from a single institution. Leuk Lymphoma 2006 0.75
64 P-stereogenic PNP pincer-Pd catalyzed intramolecular hydroamination of amino-1,3-dienes. Org Biomol Chem 2015 0.75
65 Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock. Front Med 2014 0.75
66 [Preliminary clinical investigation of coblation-assisted functional endoscopic sinus surgery for chronic sinusitis and nasal polyps]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2011 0.75
67 Publish, not perish: Introducing Experimental Hematology & Oncology. Exp Hematol Oncol 2012 0.75
68 Severe imatinib-associated muscle edema in patients with chronic myelogenous leukemia and marked leukocytosis. Leuk Lymphoma 2008 0.75
69 Highly efficient asymmetric Michael addition of aldehyde to nitroolefin using perhydroindolic acid as a chiral organocatalyst. Org Biomol Chem 2012 0.75
70 The synthesis of chiral β-aryl-α,β-unsaturated amino alcohols via a Pd-catalyzed asymmetric allylic amination. Org Biomol Chem 2013 0.75
71 Asymmetric hydrogenation of β-amino ketones with the bimetallic complex RuPHOX-Ru as the chiral catalyst. Org Biomol Chem 2013 0.75
72 [Coblation-channelling for the tongue]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2014 0.75
73 Palladium-catalyzed asymmetric hydrogenation of α-acyloxy-1-arylethanones. Angew Chem Int Ed Engl 2013 0.75
74 [Low-temperature plasma assisted via mouth for surgery treating styloid process syndrome]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2012 0.75
75 [Advances in treatment of congenital posterior choanal atresia]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2016 0.75
76 Acute myelogenous leukemia following irinotecan-based chemotherapy for adenocarcinoma of the small intestine. Leuk Lymphoma 2007 0.75
77 [Coblation for benign hyperplasia of tongue base under endoscope]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2009 0.75
78 [Lingual thyroglossal duct cyst treatment by low temperature coblation on endoscope]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2014 0.75
79 Evaluation of temozolomide in patients with myelodysplastic syndrome. Leuk Lymphoma 2004 0.75
80 Asymmetric tandem reactions of N-sulfonylimines and α,β-unsaturated aldehydes: an alternative reaction pathway to that of using saturated aldehydes. Chem Commun (Camb) 2014 0.75
81 [Revaluvation of UPPP and the pharynx in patients with snoring anatomy]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2015 0.75
82 Asymmetric domino reaction of cyclic N-sulfonylimines and simple aldehydes with trans-perhydroindolic acid as an organocatalyst. Org Lett 2014 0.75
83 [Investigation of reoperation after failure of UPPP]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2009 0.75
84 [Clinical observation of coblation under endoscopy on epiglottis cyst]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2014 0.75
85 Iridium-catalyzed allyl-allyl cross-coupling of allylic carbonates with (E)-1,3-diarylpropenes. Chem Commun (Camb) 2015 0.75
86 Pd-catalyzed asymmetric allylic amination using easily accessible metallocenyl P,N-ligands. Org Biomol Chem 2015 0.75
87 [EFFECTIVENESS OF POSTERIOR UNILATERAL TRANSPEDICULAR DEBRIDEMENT, BONE GRAFT FUSION, AND PEDICLE SCREW FIXATION FOR THORACOLUMBAL TUBERCULOSIS]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2015 0.75
88 [Expression of BDNF and trk B in the cochleas of the aged rats]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2006 0.75